BioSpace News Archive

Biotech Beach

Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis

Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis, announced $40 million in Series C equity and debt financing.

August 16, 2022
·
5 min read
FDA

Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg

Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate for Injection, 0.25 mg (Cetrorelix).

August 16, 2022
·
2 min read
Biotech Beach

Rockley Photonics to Present at Upcoming Conference

Rockley Photonics Holdings Limited today announced that it will participate in the following investor conference.

August 16, 2022
·
1 min read
BioMidwest

Strata Oncology Expands Strata PATH Trial to Eight Sarah Cannon Research Institute Sites

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that Sarah Cannon Research Institute (SCRI) has joined the Strata Precision Indications for Approved THerapies (Strata PATH™) trial.

August 16, 2022
·
3 min read
Pharm Country

BioSig Sees Positive Momentum from Sales Pipeline Growth

BioSig Technologies, Inc. announced that it is seeing positive momentum from the growth of its sales pipeline, and expects to see an increase in enterprise adoption of its PURE EP™ System in the coming months.

August 16, 2022
·
6 min read
Deals

Scryb Announces Amalgamation Agreement between Cybeats Technologies Inc. and Pima Zinc Corp.

Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) (“Scryb’’ or the “Company”) is pleased to announce that it has entered into an amalgamation agreement (the “Amalgamation Agreement”) with Pima Zinc Corp.

August 16, 2022
·
10 min read
BioMidwest

Valent BioSciences Announces Significant R&D Investments

To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.

August 16, 2022
·
3 min read
Pharm Country

Positron Corporation Announces First Step in Validation of its New PET-CT Device

Positron Corporation, a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce that its first PET-CT system has been purchased and is in transit from its partner Neusoft Medical Systems.

August 16, 2022
·
2 min read
Aesthetic Medicine Market Segmentation and Analysis Report, 2031

Wilmington, Delaware, United States, Transparency Market Research Inc. – In the last few years, the manufacturers have created novel aesthetic gadgets, resulting in a rise in demand for aesthetic treatments.

August 16, 2022
·
6 min read
Biotech Bay

Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, and Dante Genomics, a global leader in genomics and precision medicine, announced the formal commencement of ColoAlert’s consumer commercial program in Italy and the United Arab Emirates.

August 16, 2022
·
6 min read